Jun 29, 2026
17 MIN READ

What Dosage of Wegovy Do You Start Losing Weight?

Most people begin noticing appetite reduction within the first week of semaglutide therapy, though meaningful weight loss typically emerges between weeks 2 and 4 as doses gradually increase. PlexusDx provides compounded semaglutide injections starting at $149 per month with no membership fees or ...

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 29, 2026
17 MIN READ

what dosage of wegovy do you start losing weight? — PlexusDx GLP-1 education

Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, activates brain centers that regulate hunger and blood sugar. Weight loss typically begins during the dose-escalation phase, which spans 16 weeks, though individual timing depends on starting dose, metabolism, and baseline health status. Understanding this timeline helps set realistic expectations for your precision weight management journey.

How Semaglutide Triggers Weight Loss at the Cellular Level

Semaglutide works by binding to GLP-1 receptors throughout your brain, stomach, and pancreas. This activation slows gastric emptying—the rate your stomach releases food into your intestines—which extends feelings of fullness for hours after eating. Simultaneously, the medication signals your brain's satiety center to reduce hunger drive and food cravings, creating a dual mechanism that naturally lowers calorie intake without willpower alone.

The medication also improves blood sugar control and reduces insulin resistance, which independently supports weight loss by reducing fat storage signals. Clinical trials show that these effects begin within days, though measurable weight loss on the scale typically lags appetite suppression by 1 to 3 weeks. This lag occurs because your body first depletes glycogen stores and reduces water retention before mobilizing fat tissue for energy.

Starting Semaglutide Dose and First Week Results

Standard semaglutide therapy begins at 0.25 mg injected subcutaneously once weekly, a dose chosen to minimize side effects while establishing tolerability. Most patients report noticeably reduced appetite and increased feelings of fullness within 2 to 5 days of the first injection. Some experience mild nausea or changes in bowel habits during this initial phase, which typically resolve within 3 to 7 days as the body adapts.

The dose remains at 0.25 mg for the first month, allowing your system to stabilize before the escalation phase begins. During this week, scale weight may remain stable or increase slightly due to normal fluid shifts, but appetite suppression often becomes the most obvious sign that the medication is working. PlexusDx patients receive personalized guidance on what to expect during this adjustment window and how to support tolerance through nutrition choices.

Progressive Dosing Schedule and Weight Loss Timeline

After the initial 0.25 mg phase, doses increase by 0.25 mg increments every 4 weeks: 0.25 mg (weeks 1–4), 0.5 mg (weeks 5–8), 0.75 mg (weeks 9–12), and 1.0 mg (weeks 13–16). Most meaningful weight loss emerges during weeks 4 through 8, when cumulative appetite suppression and metabolic improvements intersect. Average weight loss during this period ranges from 2 to 4 pounds per week, though individual results vary based on starting weight, diet quality, and physical activity level.

By week 12 to 16, when doses reach the standard maintenance level of 1.0 mg weekly, weight loss typically accelerates further if dietary adherence remains consistent. Clinical trials document average total weight loss of 15% of starting body weight by 68 weeks of continuous therapy. Importantly, semaglutide's full appetite-suppressing effect emerges gradually across the dose-escalation phase, meaning your starting dose is not your therapeutic dose—it is your tolerance-building dose. PlexusDx's flat monthly pricing means your dose may need to go up, but your price won't.

Factors That Affect Your Individual Weight Loss Timeline

Genetic variation in GLP-1 receptor sensitivity, determined by variants such as GLP1R rs6923761, influences how quickly you respond to semaglutide and at what dose your appetite suppression peaks. Metabolic factors including baseline insulin resistance, resting metabolic rate, and thyroid function also shape the pace and magnitude of weight loss. PlexusDx's Precision Peptide Genetic Test maps 14 peptide-signaling pathways and 150+ genetic insights to identify your individual response profile, allowing your prescriber to optimize timing and dosing strategy for your unique biology.

Behavioral and dietary factors equally influence results: consistent calorie deficit, adequate protein intake, regular physical activity, and sleep quality all accelerate and sustain weight loss beyond medication alone. Patients who experience gastrointestinal side effects may require slower dose escalation, which delays reaching therapeutic doses but does not prevent eventual weight loss success. Age, hormonal status, and medications that affect appetite or metabolism also contribute to individual variation in the semaglutide weight loss timeline.

Compounded Semaglutide vs. Brand-Name Wegovy: Dosing Equivalence

PlexusDx compounded semaglutide injections contain the same active pharmaceutical ingredient as brand-name Wegovy, manufactured by licensed 503A compounding pharmacies that follow FDA quality standards. Both follow identical dose-escalation protocols and produce comparable weight loss results when administered at equivalent doses. The primary difference lies in cost and access: PlexusDx semaglutide begins at $149 per month with no insurance requirement, no membership fee, and HSA/FSA eligibility, whereas brand-name alternatives often cost $900 to $1,400 monthly with insurance barriers.

Clinical equivalence means that the weight loss timeline—onset of appetite suppression, meaningful weight loss emergence around week 4, and continued progress through the escalation phase—remains identical whether you use compounded or brand-name semaglutide. Quality assurance at 503A compounding pharmacies includes sterility testing, potency verification, and identity confirmation, ensuring your medication meets pharmaceutical standards. PlexusDx serves all 50 states and makes semaglutide therapy accessible without requiring insurance or membership commitments.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

When will I see the number on the scale go down after starting semaglutide?

Most patients experience appetite reduction within days of their first injection, but measurable weight loss on the scale typically begins between weeks 2 and 4 as doses increase and appetite suppression deepens. Individual timelines vary based on starting weight, metabolism, and adherence to a calorie deficit. PlexusDx providers help set realistic expectations and monitor progress through the escalation phase.

Is there clinical evidence that semaglutide causes weight loss at all doses?

Yes. Clinical trials including the STEP program demonstrated weight loss at all semaglutide doses above placebo, with greater loss at higher doses. The 0.25 mg starting dose produces modest appetite suppression and modest weight loss; the 1.0 mg maintenance dose produces substantial appetite suppression and clinically meaningful weight loss averaging 10 to 15% of body weight.

How much does compounded semaglutide cost at PlexusDx compared to brand Wegovy?

PlexusDx compounded semaglutide injections start at $149 per month, with pricing remaining flat regardless of dose level. Brand-name Wegovy typically costs $900 to $1,400 monthly. PlexusDx requires no insurance, no membership fee, and accepts HSA/FSA funds, making semaglutide therapy accessible across all 50 states.

Are there serious side effects that might delay my semaglutide dosing?

Common side effects include nausea, constipation, and reduced appetite for protein-rich foods, which typically resolve within 1 to 2 weeks. Serious side effects are rare but include pancreatitis and gallbladder issues. If side effects prevent dose escalation, your PlexusDx provider may slow the titration schedule while monitoring safety, though this extends rather than prevents weight loss success.

Can genetic testing help predict when my semaglutide weight loss will begin?

PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, MC4R, and FTO genes that influence your receptor sensitivity and metabolic response to semaglutide. These insights help your provider personalize your dosing timeline and predict whether you may respond optimally at standard doses or benefit from alternative compounds. The test costs $99 as an add-on after your first month of treatment.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves